Seeing Is Believing
Currently out of the existing stock ratings of Douglas Miehm, 18 are a HOLD (40%), 27 are a BUY (60%).
Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 59.72% that have a potential upside of 38.76% achieved within 146 days.
Douglas Miehm’s has documented 90 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BHC, Bausch Health Companies at 30-Jan-2025.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$5.21 (66.88%)
$13
5 months 9 days ago
(06-Sep-2024)
10/22 (45.45%)
$5.74 (79.06%)
579
Hold
$6
$-1.79 (-22.98%)
$26
9 months 13 days ago
(02-May-2024)
3/3 (100%)
$0.83 (16.05%)
398
Buy
$8
$0.21 (2.70%)
$11
11 months 30 days ago
(16-Feb-2024)
8/12 (66.67%)
$2.15 (36.75%)
152
Hold
$13
2 years 3 months 11 days ago
(04-Nov-2022)
5/9 (55.56%)
$4.73 (57.19%)
203
Buy
$12
$4.21 (54.04%)
$22
2 years 3 months 11 days ago
(04-Nov-2022)
1/4 (25%)
$6.85 (133.01%)
266
Which stock is Douglas Miehm is most bullish on?
Which stock is Douglas Miehm is most reserved on?
What Year was the first public recommendation made by Douglas Miehm?